CWM
BIIB icon

Concert Wealth Management’s Biogen BIIB Stock Holding History

Concert Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-600
Closed -$2K – 678
2015
Q4 		$2K Buy
+600
New +$172K ﹤0.01% 684
2015
Q3 		– Sell
-500
Closed -$2K – 704
2015
Q2 		$2K Buy
+500
New +$201K ﹤0.01% 698

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Concert Wealth Management's BIIB Position: Q2 2017 in Review

Concert Wealth Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 1,872 shares — an estimated $533K sold.

Concert Wealth Management first reported a position in BIIB in Q2 2013 and held it in 16 quarters. The position peaked at $2.02M in Q4 2015. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Concert Wealth Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 1,872 Biogen shares in Q2 2017, an estimated $533K.
  • Concert Wealth Management first reported a position in Biogen in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Biogen position peaked at $2.02M in Q4 2015.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.